Target intelligence / Profile preview

Ferredoxin 1 pseudogene 2 (FDX1P2)

Target: FDX1P2
Molecular classification: Other (Pseudogene; not an enzyme, receptor, transporter, channel, etc.)

Overview

Ferredoxin 1 pseudogene 2 (FDX1P2) is a non-coding genomic sequence homologous to the electron transfer protein ferredoxin 1 (FDX1)[1]. Unlike FDX1, which contributes to mitochondrial steroid, vitamin D, and bile acid metabolism by shuttling electrons to cytochrome P450, FDX1P2 does not encode a functional protein and serves no direct biological or therapeutic role. Pseudogenes are commonly found across the genome and can sometimes participate in gene regulation or genomic rearrangement, but FDX1P2 itself is not defined as a drug target or molecular receptor[1][3][4]. If a drug or research target is intended, the proper entry is "Ferredoxin 1 (FDX1)," not FDX1P2[1][3].

Other names: FDX1P2Ferredoxin 1 pseudogene 2

Beyond the preview

Go deeper on Ferredoxin 1 pseudogene 2 (FDX1P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ferredoxin 1 pseudogene 2 (FDX1P2).

Explore the full profile